Induction of HL-60 cells to undergo apoptosis is determined by high levels of wild-type p53 protein whereas differentiation of the cells is mediated by lower p53 levels

Cell Growth and Differentiation

Volumn 7, Issue 1, 1996, Pages 21-30

  Ronen, Dvora ^a   Schwartz, Dov ^b   Teitz, Yael ^a   Goldfinger, Naomi ^b   Rotter, Varda ^b  

^a TEL AVIV UNIVERSITY   (Israel)

^b WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

APOPTOSIS; ARTICLE; CELL CYCLE; CELL DIFFERENTIATION; CELL STRAIN HL 60; CONTROLLED STUDY; GENE EXPRESSION REGULATION; HEMATOPOIETIC SYSTEM TUMOR; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; PRIORITY JOURNAL; PROTEIN DETERMINATION; TUMOR SUPPRESSOR GENE; VACCINIA VIRUS;

APOPTOSIS; BLOTTING, WESTERN; CELL CYCLE; CELL DIFFERENTIATION; CELL SEPARATION; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION, VIRAL; HL-60 CELLS; HUMANS; KINETICS; RECOMBINANT PROTEINS; TUMOR SUPPRESSOR PROTEIN P53; VACCINIA VIRUS;

VACCINIA; VACCINIA VIRUS;

EID: 0030031757     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (62)

1. Hollstein, M., Sidransky, D , Vogelstein, B., and Harris, C. C. p53 mutations in human cancers. Science (Washington DC), 253: 49-53, 1991.
2. Lane, D. P., and Benchimol, S. p53: oncogene or anti-oncogene? Genes & Dev., 4: 1-8, 1990.
3. Levine, A. J., Momand, J., and Finlay, C. A. The p53 tumour suppression gene. Nature (Lond.), 351: 453-456, 1991.
4. Harris, C. C. p53: at the crossroads of molecular carcinogenesis and risk assessment. Science (Washington DC), 262: 1980-1981, 1993.
5. Vogelstein, B. A deadly inheritance. Nature (Lond), 348: 681-682, 1990.
6. Vogelstein, B., and Kinzler, K W. p53 function and dysfunction. Cell, 70: 523-526, 1992
7. El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., and Vogelstein, B. WAF1, a potential mediator of p53 tumor suppression. Cell, 75: 817-825, 1993.
8. 1 cyclin-dependent kinases. Cell, 75: 805-816, 1993.
9. Shaulsky, G., Ben-Zeev, A , and Rotter, V. Subcellular distribution of the p53 protein during the cell cycle of Balb/c 3T3 cells. Oncogene, 5: 1707-1711, 1990.
10. Ginsberg, D., Michael-Michaelovitz, D., and Oren, M. Induction of growth arrest by a temperature-sensitive p53 mutant is correlated with increased nuclear localization and decreased stability of the protein. Mol. Cell. Biol., 11: 582-585, 1991.
11. Martinez, J., Georgoff, I., Martinez, J., and Levine, A. J. Cellular localization and cell cycle regulation by a temperature sensitive protein. Genes & Dev., 5: 151-159, 1991.
12. Wilcock, D., and Lane, D. P. Localization of p53, retinoblastoma and host replication proteins at sites of viral replication in herpes-infected cells. Nature (Lond.), 349: 423-431, 1991.
13. Deppert, W., Buschhausen-Denker, G., Patschinsky, T., and Steinmeyer, K. Cell cycle control of p53 in normal (3T3) and chemically transformed (Meth A) mouse cells. II. Requirement for cell cycle progression. Oncogene, 5: 1701-1706, 1990.
14. Diller, L., Kassel, J., Nelson, C. E., Gryka, M. A., Litwak, G., Gebhardt, M., Bressac, B , Ozturk, M., Baker, S. J., Vogelstein, B., and Friend, S. H. p53 functions as a cell cycle control protein in osteosarcomas. Mol. Cell. Biol., 10: 5772-5781, 1990.
15. Shaulsky, G , Goldfinger, N., Peled, A., and Rotter, V. Involvement of wild type p53 in pre-B cell differentiation in vitro. Proc. Natl Acad. Sci. USA, 88: 8982-8986, 1991.
16. 2-dependent immunoglobulin K light chain gene expression. EMBO J., 14: 1392-1401, 1995.
17. 2/M by p53. Oncogene, 10: 109-115, 1994.
18. Cross, S. M., Sanchez, C. A., Morgan, C A., Schimke, M. K., Ramel, S., Idzerda, R. L., Raskind, W. H., and Raid, B. J. A p53-dependent mouse spindle checkpoint. Science (Washington DC), 267: 1353-1356, 1995
19. Maltzman, W., and Czyzyk, L. UV irradiation stimulates levels of p53 cellular tumor antigen m nontransformed mouse cells. Mol. Cell Biol., 4: 1689-1694, 1984.
20. Kastan, M. B., Onyekwere, O., Sidransky, D., Vogelstein, B., and Craig, R W. Participation of p53 protein in the cellular response to DNA damage. Cancer Res , 51: 6304-6311, 1991.
21. Kastan, M. B., Zhan, Q., El-Deiry, W S., Carrier, F., Jacks, T., Walsh, W. V., Plunket, B. S., Vogelstein, B., and Fornace, A. J. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell, 71: 537-537, 1992.
22. Kuerbitz, S. J., Plunkett, B. S., Walsh, W. V., and Kastan, M. B. Wild-type p53 is a cell cycle checkpoint determinant following irradiation Proc. Natl. Acad. Sci. USA, 89: 7491-7495, 1992
23. Lane, D. P. p53, guardian of the genome. Nature (Lond.). 358: 15-16, 1992
24. Livingstone, L. R., White, A., Sprouse, J., Livanos, E., Jacks, T., and Tlsty, T. D. Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53. Cell, 70: 923-935, 1992.
25. Yonish-Rouach, E., Resnitzky, K., Lotem, J , Sachs, L., Kimchi, A., and Oren, M. Wild type p53 induces apoptosis of myeloid leukemic cells that is inhibited by interleukin 6. Nature (Lond.), 352: 345-347, 1991.
26. Yonish-Rouach, E., Grunwald, D., Wilder, S., Kimchi, A., May, E., Lawrence, J. J , May, P., and Oren, M. p53-mediated cell death: relationship to cell cycle control. Mol. Cell. Biol , 13: 1415-1423, 1993.
27. Shaw, P., Bovey, R., Tardy, S., Sahli, R., Sordat, B., and Costa, J. Induction of apoptosis by wild-type p53 in a human colon tumor-derived cell line. Proc. Natl. Acad. Sci. USA, 89: 4495-4499, 1992.
28. Williams, G. T., and Smith, C. A. Molecular regulation of apoptosis: genetic controls on cell death. Cell, 74: 777-779, 1993.
29. Shaulsky, G., Goldfinger, N . and Rotter, V. Alterations in tumor development in vivo mediated by expression of wild type or mutant p53 proteins. Cancer Res., 51: 5232-5237, 1991
30. Aloni-Grinstein, R., Zan-Bar, I., Alboum, I., Goldfinger, N., and Rotter, V. Wild type p53 functions as a control protein in the differentiation pathway of the B-cell lineage. Oncogene, 8: 3297-3305, 1993.
31. Rotter, V., Aloni-Grinstein, R., Schwartz, D., Elkind, N. B., Simons, A., Wolkowicz, R., Lavigne, M., Besserman, P., Kapon, A., and Goldfinger, N. Does wild type p53 play a role in normal cell differentiation? Semin. Cancer Biol., 5: 229-236, 1994.
32. Schwartz, D., Goldfinger, N., and Rotter, V. Expression of p53 protein in spermatogenesis is confined to the tetraploid pachytene primary spermatocytes. Oncogene, 8: 1487-1494, 1993.
33. Kastan, M. B., Radin, A. I., Kuerbitz, S. J., Onyekwere, O., Wolkow, C A., Civin, C. I., Stone, K. D., Woo, T., Ravindranat, H., and Crag, R. W. Levels of p53 protein increase with maturation in human hematopoietic cells. Cancer Res., 51: 4279-4286, 1991.
34. Johnson, P., Chung, S., and Benchimol, S. Growth suppression of Friend virus-transformed erythroleukemia cells by p53 protein is accompanied by hemoglobulin production and is sensitive to erythropoitin. Mol. Cell. Biol., 13: 1456-1463, 1993.
35. Feinstein, E., Gale, P. B., Reed, J., and Cannai, E. Expression of the normal p53 gene induces differentiation of K562 cells. Oncogene, 7: 1853-1857, 1992.
36. Soddu, S., Blandino, G., Citro, G., Scardigli, R., Piaggio, G., Ferber, A., Calabretta, B , and Sacchi, A. Wild-type p53 gene expression induces granulocytic differentiation of HL-60 cells. Blood, 83: 2230-2237, 1994.
37. Lu, X., and Lane, D. P. Differential induction of transcriptionally active p53 following UV or ionizing irradiation: defects in chromosome instability syndromes? Cell, 75: 765-773, 1993.
38. Nelson, W. G., and Kastan, M. B. DNA strand breaks: the DNA template alteration that triggers p53 dependent DNA damage response pathways. Mol. Cell. Biol., 14: 1815-1823, 1994.
39. 1 arrest and long-term induction of Cip1 in normal human fibroblasts. Genes & Dev., 8: 2540-2551, 1994.
40. Woodworth, C. D., Wang, H., Simpson, S., Alvarez-Salas, L. M., and Notario, V. Overexpression of wild-type p53 alters growth and differentiation of normal human keratinocytes but not human papillomavirus-expressing cell lines. Cell Growth & Differ., 4: 367-376, 1993.
41. 1. Cell Growth & Differ., 4: 993-1004, 1993.
42. Wolf, D., and Rotter, V. Major deletions in the gene encoding the p53 antigen cause lack of p53 expression in HL-60 cells. Proc. Natl. Acad. Sci. USA, 82: 790-794, 1985.
43. Ronen, D., Teitz, Y., Goldfinger, N., and Rotter, V Expression of wild-type and mutant p53 proteins by recombinant vaccinia viruses. Nucleic Acids Res., 20: 3435-3441, 1992.
44. Collins, S. J., Ruscetti, F. W., Gallagher, R. E., and Gallo, R. C. Terminal differentiation of human promyelocytic leukemia cells induced by dimethyl sulfoxide and other polar compounds. Proc. Natl. Acad. Sci. USA, 75: 2458-2462, 1978.
45. Jiag, H., Lin, J., Su, Z. Z., Collart, F. R., Huberman, E , and Fisher, P. B. Induction of differentiation in human promyelocytic HL-60 leukemia cells activates p21 WAF1/CIP1 expression in the absence of p53. Oncogene, 9: 3397-3406, 1994
46. Zhang, W , Grasso, L., McClain, C. D , Gambel, A. M., Cha, Y , Travali, S., Deisseroth, A. B., and Mercer, W. E p53-independent induction of WAF1/CIP1 in human leukemia cells is correlated with growth arrest accompanying monocyte/macrophage differentiation. Cancer Res., 55: 668-674, 1995.
47. Eliyahu, D., Goldfinger, N., Pinhasi-Kimhi, O., Shaulsky, G., Skurnik, Y., Arai, N., Rotter, V., and Oren, M. Meth-A fibrosarcoma cells express two transforming mutant p53 species. Oncogene, 3: 313-321, 1988.
48. Eliyahu, D., Michalovitz, D., Eliyahu, S., Pinhasi-Kimhi, O., and Oren, M. Wild-type p53 can inhibit oncogene-mediated focus formation Proc. Natl Acad Sci. USA, 86: 8763-8767, 1989.
49. Finlay, C. A., Hinds, P. W , and Levine, A. J. The p53 proto-oncogene can act as a suppressor of transformation. Cell, 57: 1083-1093, 1989.
50. Mercer, W. E., Shields, M T., Lin, D., Appella, E., and Ullrich, S. J. Growth suppression induced by wild-type p53 protein is accompanied by selective down-regulation of proliferating-cell nuclear antigen expression. Proc. Natl. Acad. Sci. USA, 83: 1958-1962, 1991.
51. Mercer, W. E., Shields, M. T., Amin, M., Sauve, G J , Appella, E., Romano, J. W., and Ullrich, S. J. Negative growth regulation in a glioblastoma tumor cell line that conditionally expresses human wild type p53. Proc. Natl. Acad. Sci. USA, 87: 6166-6170, 1990.
52. Baker, S. J., Markowitz, S., Fearon, E. R., Wilson, J. K. V., and Vogelstein, B. Suppression of human colorectal carcinoma cell growth by wild-type p53. Science (Washington DC), 249: 912-915, 1990.
53. Rodriguez, N. R., Rowan, A., Smith, M. E. F., Kerr, I. B., Bodmer, W. F., Gannon, J. V., and Lane, D. P. p53 mutations in colorectal cancer. Proc. Natl. Acad. Sci. USA, 87: 7555-7559, 1990.
54. Rotter, V. p53, a transformation-related cellular encoded protein, can be used as a biochemical marker for the detection of primary mouse tumor cells. Proc. Natl. Acad. Sci. USA, 80: 2613-2617, 1983.
55. Nigro, J. M., Baker, J. S., Preisinger, A. C., Jessup, J. M , Hostetter, K., Cleary, K., Bigner, S. H., Davidson, N., Baylin, S., Devilee, P., Glover, T , Collins, F. S., Weston, A., Modali, R., Harris, C. C., and Vogeistein, B. Mutations in the p53 gene occur in diverse human tumour types. Nature (Lond.), 342: 705-708, 1989.
56. Mulligan, L. M., Matlashewski, G. J., Scrable, H. J., and Cavenee, W K, Mechanisms of p53 loss in human sarcomas. Proc. Natl. Acad. Sci. USA, 87: 5683-5867, 1990.
57. Prokocimer, M., and Rotter, V. Structure and function of p53 in normal cells and their aberrations in cancer cells: projection on the hematological cell lineage. Blood, 84: 2391-2411, 1994.
58. Darzynkiewicz, Z., Bruno, S., Del Bino, G., Gorczyca, W., Hotz, M. A., Lassota, P., and Traganos, F. Features of apoptotic cells measured by flow cytometry. Cytometry, 13: 795-808, 1992.
59. Afanasyev, V. N., Korol, B. A., Matylevich, N. P., Pechatnikov, V. A., and Umansky, S. R. The use of flow cytometry for the investigation of cell death. Cytometry, 14: 603-609, 1993.
60. Harlow, E., Crawford, L V., Pim, D. C., and Williamson, N. M. Monoclonal antibodies specific for simian virus 40 tumor antigen. J. Virol., 39: 861-869, 1981.
61. Gannon, J. V., Greaves, R., Iggo, R., and Lane, D. P. Activating mutations in p53 produce a common conformational effect: a monoclonal antibody specific for the mutant form. EMBO J., 9: 1595-1602, 1990
62. Yewdell, J. W., Gannon, J. V., and Lane, D. P. Monoclonal antibody analysis of p53 expression in normal and transformed cells. J. Virol., 59: 444-452, 1986.